ARTICLE | Company News
Scangos leaving Exelixis for Biogen Idec
June 30, 2010 11:47 PM UTC
George Scangos will depart as president and CEO of cancer company Exelixis Inc. (NASDAQ:EXEL) to become CEO and a director of Biogen Idec Inc. (NASDAQ:BIIB), effective July 15. Scangos will replace James Mullen, who retired. ...